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Background: Lower extremity peripheral arterial disease (PAD), commonly identified by 
an ankle-brachial Index (ABI) <0.9, increases mortality risk and may impair quality of life 
(QOL). However, most studies assessing reduced QOL in the relation to PAD rely on 
small clinical studies, leaving uncertainty about the impact of PAD on QOL in the 
community.  
Methods: Using data of 5,115 ARIC visit 5 (2011-2013) participants aged 66-90 years, 
we assessed the associations of ABI with several QOL parameters, including physical 
and mental components in SF-12 as well as some other QOL parameters (leisure time 
exercise/activity/walking, depression, and hopeless feeling. We used linear/logistic 
regression models to adjust for demographic characteristics, cardiovascular disease 
(CVD) risk factors, history of CVD, and other comorbidities including lung disease and 
reduced kidney function. 
Results: There were 402 participants with low ABI < 0.90 and 426 participants with 
borderline low ABI (0.90-0.99). Overall, there were dose-response relationships between 
lower ABI and poor status of QOL parameters. With ABI 1.10-1.19 as a reference 
(n=1900), the associations of low ABI (< 0.90) and impaired QOL were much more 
evident in physical components (Physical Component Summary: -3.27 [95%CI: -5.60 to 
-0.93]), compared to mental components (Mental Component Summary: -0.07 [95%CI: 
 iii 
-2.21 to 2.06]). Regarding each of eight domains in SF-12, low ABI was significantly 
associated with all four domains for physical components (Physical Functioning, Role 
Physical, Bodily Pain, and General Health) but only with one of four domains for mental 
components (vitality). Similarly low ABI was more consistently associated with the other 
physical QOL parameters than the other mental parameters. Interestingly, a poor status 
of several QOL parameters was also observed in borderline low ABI. Similar results for 
lower ABI and physical QOL parameters were observed in subgroups according to sex, 
race as well as history of CVD, diabetes, and reduced kidney function. 
Conclusions: Lower ABI was independently associated with poor status of QOL, 
especially on physical, with potential important implications on quality-maintained life in 
older individuals. Further studies are warranted to assess if the PAD-specific 
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 Peripheral artery disease (PAD) has high prevalence in older population. Usually 
combined with other cardiovascular comorbidities, PAD patients’ prognoses are not 
optimistic. On the other hand, PAD itself could affect patients’ moving ability and may 
reduce their quality of life (QOL). This study focused on the impact of PAD on quality of 
life in general older populations. Using ankle-brachial index (ABI) as an indicator, we 
explored the potential quantitative association between ABI and multiple health-related 
QOL elements and wished to provide some advices on QOL management in PAD 







 We thank the patients, staff, researchers, and laboratory for their participation in 
the ARIC Study. National Heart, Lung, and Blood Institute (NHLBI) funds the study by 
contracts: N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, 
N01-HC-55020, N01-HC-55021, and N01-HC-5502. The neurocognitive data is 





ABSTRACT .......................................................................................................... ii 
PREFACE............................................................................................................ iv 
CONTENTS .......................................................................................................... v 
LIST OF TABLES ................................................................................................ vi 
LIST OF FIGURE ............................................................................................... vii 
INTRODUCTION .................................................................................................. 1 
METHODS............................................................................................................ 3 
RESULTS ............................................................................................................. 9 
DISCUSSION ..................................................................................................... 13 
APPENDICES .................................................................................................... 17 
BIBLIOGRAPHIES ............................................................................................. 30 
CURRICULUM VITAE ........................................................................................ 36 
 vi 
LIST OF TABLES 
Main Tables 
1. Table 1. Participant’s characteristics description across ABI categories.  P17 
2. Table 2. The difference in QOL scores across ABI categories.    P18 
3. Table 3. Odds-ratio of other QOL parameters across ABI categories.   P19 
 
Supplementary Tables 
1. Supplementary Table 1. Description of participant’s SF-12 QOL parameters across 
ABI categories.       P21 
2. Supplementary Table 2. The difference in QOL scores across ABI categories using 
Model 1.       P22  
3. Supplementary Table 3. The difference in QOL scores across ABI categories using 
Model 2.       P23  
4. Supplementary Table 4. Odds-ratio of other QOL parameters across ABI categories 
using Model 1.       P24 
5. Supplementary Table 5. Odds-ratio of other QOL parameters across ABI categories 
using Model 2.       P25 
6. Supplementary Table 6. The difference in Physical Component Summary scores 
across ABI categories in different subgroups.       P26 
7. Supplementary Table 7. The difference in Mental Component Summary scores 
across ABI categories in different subgroups.       P27 
8. Supplementary Table 8. Odds-ratio of other physical activity parameters for lower ABI 
(<1.00) in different subgroups.       P28 
9. Supplementary Table 9. Odds-ratio of other mental health parameters for lower ABI 
(<1.00) in different subgroups.       P29 
 vii 
LIST OF FIGURE 
Figure 1. The difference in QOL scores across ABI categories (Physical / Mental 
Component Summary from SF12)            P20 
 1 
INTRODUCTION 
Peripheral arterial disease (PAD), commonly identified by an ankle brachial index (ABI) 
less than 0.9, is increasingly important,1 especially in older adults. In the US, PAD affects 
over 8 millions individuals,2 including about 20% of people aged over 70 years.3, 4 
Persons with PAD have 3 to 5 fold higher mortality risk compared with those without PAD, 
which is mainly due to higher risk of cardiovascular diseases (CVD),5-7 reflecting the 
property of PAD as a manifestation of systemic atherosclerosis.8 
 PAD also has impact on quality of life (QOL). As the disease progresses, patients 
with PAD may develop intermittent claudication and critical limb ischemia (a condition 
including ischemic rest pain, ulcers, or gangrene, with up to 25% of amputation risk within 
one year after diagnosis),9 leading to reduction of health-related QOL. Indeed, several 
studies confirm this aspect of PAD,10-15 but these results came from small studies or 
predominantly investigated clinical population mainly with symptomatic PAD, leaving 
uncertainty about the impact of PAD on QOL in the community. 
 Therefore, the aim of this study is to comprehensively investigate the full spectrum 
of ABI and its association with health-related QOL among older adults in the community 
using data from the Atherosclerosis Risk in Communities Study (ARIC) Study. Since the 
relative importance of QOL over prognosis becomes larger as one ages16 and 
PAD-specific management (e.g., supervised exercise) has been shown to improve QOL, 
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The ARIC Study is an ongoing prospective cohort to investigate the natural history of 
atherosclerosis and related cardiovascular event and consists of 15,792 participants 
aged 45–64 at baseline visit in 1987–1989 from four U.S. communities, Forsyth County, 
North Carolina, Jackson, Mississippi, suburbs of Minneapolis, Minnesota, and 
Washington County, Maryland. The ARIC Study conducted fifth examination between 
June 1st, 2011 and August 30th, 2013, at which 6,538 participants aged 66-90 years 
attended. Of these visit attendees, we excluded 18 non-Caucasian/non-African American 
participants, and additional 868 participants without ABI measurement. In addition, 537 
participants with missing information for covariates and QOL data were further excluded, 
leaving the final population of 5,115 participants for this study.  
 
ABI Measurement 
Ankle-brachial index was defined as the ratio of systolic blood pressure in the ankle 
divided by the systolic pressure in the arm. Using an oscillometric device, OMRON 
VP-1000 plus (Kyoto, Japan), blood pressure was automatically and simultaneously 
measured in both ankles and arms by trained and certified technicians.17 Using higher 
value of right and left arm blood pressure as denominator, ABI was calculated for right 
and left legs. The measurement was repeated after five minutes, and the mean ABI was 
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recorded for right and left legs. The lower value of right and left ABI was used for this 
analysis in general. One exception was when both ABIs are greater than 1.0 and at least 
one ABI was higher than 1.3. In this scenario, to capture pathophysiological information 
of high ABI (indicating arterial stiffness and calcification),2, 18-20 we used higher ABI value 
for our analysis.  
 
Health-related quality of life (QOL) 
Our primary measure of health-related QOL relied on 12-item Short-Form Health Survey 
(SF-12), which captures both physical and mental elements of health-related QOL. To 
assess the robustness of our findings, we also evaluated physical activity and hopeless 
feeling based on self-report and depression based on the Epidemiologic Studies 
Depression Scale (CES-D) Short Form. 
 
12-item Short-Form Health Survey (SF-12) 
SF-12 questionnaire is designed for health-related QOL assessment that has been 
validated across populations,21, 22 and is comparable to the original full form of SF-36.21, 23 
It reports two summary measurements for physical and mental health-related QOL, i.e., 
Physical Component Summary and Mental Component Summary. Each summary 
component was based on four domains: Physical Component Summary - physical 
functioning (the ability to do moderate activities / climb stairs), role-physical (impaired 
working ability / daily activities due to physical issue), bodily pain (extend to which pain 
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interfere daily work), and general health (self-grading health status); Mental Component 
Summary - mental health (whether feel peaceful or depressed), role-emotional (impaired 
working ability / daily activities due to emotional issue), social functioning (frequency of 
social activities interfered by physical/emotional issues), and vitality (whether feel 
energetic). Although detailed calculation for QOL score can be found elsewhere,24 briefly, 
QOL score between 0 and 100 for each domain was given to each participant according 
to one or several questions with 3 or 5 points scale and high score indicates high QOL. 
The QOL score is standardized to general U.S. population with a mean of 50 and a 
standard deviation of 10. 
 
Other health-related QOL variables 
Leisure time exercise frequency, activity level comparing to peers, and walking frequency 
were collected with questionnaire during interview. We defined participants who reported 
“never” or “seldom” for leisure time exercise as “low” leisure time exercise (n=2,483) and 
defined those reported “much less” or “less” for leisure time activity level comparing to 
peers as “low” leisure time activity (n=900). We also defined participants who reported 
“never” or “seldom” for leisure time walking frequency as “low” leisure time walk 
(n=1,507). 
 The CES-D Short Form is a depression related symptom measurement instrument, 
with 11 items selected from the full CES-D Form with 20 items and demonstrates good 
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validity25 and high correlation with the full CES-D Form (Pearson r = 0.95).26 With a scale 
between 0 and 2 (0 = hardly ever or never; 1 = some of the time; 2 = much or most of the 
time) for each item, the total CES-D score can be between 0 and 22. The score was 
treated as missing if more than 1 item were missing. Depression was defined as CES-D 
score ≥9 (n=310).17 Information about the frequency of feeling hopeless in the past week 
(<1 day, 1-2 days, 3-7 days) was gathered via a simple question asking during the 
interview. Hopeless feeling was defined by having hopeless feeling at least 1 day in the 
previous week (n=520). 
 
Covariates 
Age, sex, ethnicity, were self-reported. Information of education level (high school or 
lower vs. college or above) was collected during ARIC visit 1 interview. Self-indicated 
economic status was based on self-estimated rank of family financial situation comparing 
to the whole US population, with 10 categories. Lower self-indicated economic status was 
defined as having a score < 6 (median score in the study participants). Body mass Index 
was calculated as weight (kg) divided by the square of height (m). Total cholesterol was 
assessed via enzymatic methods.27 Glucose level was measured by 
hexokinase/glucose-6-phosphate dehydrogenase methods.28 Diabetes was defined as 
fasting glucose level ≥126 mg/dL (or 7 mmol/L), non-fasting glucose level ≥200 mg/dL (or 
11.1 mmol/L), medication use for diabetes, or self-reported physician diagnosis. 
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Hypertension was defined as systolic blood pressure (mean of the 2nd and 3rd 
measurements in sitting position) ≥140 mmHg or diastolic blood pressure ≥90 mmHg or 
use of anti-hypertensive medication. History of coronary heart disease and stroke was 
identified by the clinical history acquired at visit 1 and CHD and stroke events between 
visits 1 and visit 5, respectively. History of heart failure (HF) was defined as definite, 
probable, or chronic stable HF by an ARIC physician adjudication panel or hospitalization 
with ICD code 428.x prior to Visit 5, HF diagnosis confirmed with participants’ physicians. 
Lung disease was based on the self-reported physician diagnosis of emphysema/chronic 
obstructive pulmonary disease, chronic bronchitis or asthma. Estimated glomerular 
filtration rate (eGFR) was derived using the CKD-EPI equation incorporating serum 




According to clinical guidelines and previous literature,20, 30, 31 ABI value was categorized 
into six groups: <0.90, 0.90-0.99, 1.00-1.09, 1.10-1.19, 1.20-1.29, ≥1.30. The category of 
1.10-1.19 was used as reference since it was the most prevalent category in our study 
and was used as a reference in a previous meta-analysis.32 Participants’ baseline 
characteristics were compared across these six ABI groups based on chi-square tests 
and ANOVA tests, as appropriate. We ran linear regression models for continuous QOL 
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parameters from SF-12 (two summary components and eight health-related domains) 
and logistic regression models for the other QOL variables related to leisure time physical 
activity and mental status (“low” leisure time exercise/activity/walking, depression and 
hopeless feeling). To evaluate the influence of potential confounders, three models were 
constructed. Model 1 adjusted for demographic variables, age, sex, ethnicity, education 
level, and self-indicated economics status. Model 2 further adjusted for CVD risk factors 
(current smoking/drinking status, body mass index, total cholesterol level, diabetes, 
hypertension) and history of CVD (history of CHD, heart failure and stroke). Model 3 
additionally included the presence of lung disease and reduced kidney function. Since we 
are particularly interested in the independent association of ABI with health-related QOL, 
we primarily demonstrate results based on Model 3. We repeated the analysis in 
subgroups according to sex, race, and the status of CVD history, diabetes, and reduced 
kidney function. In this subgroups analysis, we kept six ABI categories for continuous 
QOL parameters but, to obtain reliable estimates, analyzed dichotomous ABI (<1.00 and 





The mean age of 5,115 participants was 75.4 (SD 5.0) years, and 21.8% (n=1,113) were 
African American. There were 402 participants (7.9%) with low ABI <0.90, a category 
considered as PAD, and 426 (8.3%) with borderline low ABI of 0.90-0.99. As compared to 
participants with ABI 1.10-1.19, those with lower ABI tended to have worse 
cardiovascular risk factor profile, namely older age, lower socioeconomic status, higher 
prevalence of current smokers, diabetes, hypertension, history of cardiovascular, lung 
disease and reduced kidney function (Table 1). Those with high ABI (≥1.30) also 
demonstrated worse profile for some risk factors and clinical conditions such as older age, 
higher adiposity, and higher prevalence of diabetes, and prior history of cardiovascular 
disease compared to those with ABI 1.10-1.19. 
 
12-item Short-Form Health Survey (SF-12) 
In the overall study population, the mean score for Physical/Mental Component Summary 
was 46.8 (SD 9.9) and 55.5 (SD 7.5), respectively (Supplementary Table 1.). With the 
reference of ABI 1.10-1.19, ABI categories <1.00 demonstrated significantly lower score 
for Physical Component Summary (-3.26 [95%CI: -5.60 to -0.92] for ABI <0.90 and -2.23 
[95%CI: -4.07 to -0.39] for ABI 0.90-0.99). On the other hand, the difference was not 
evident for Mental Component Summary. (Figure 1) When we looked at each domain 
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separately, ABI <0.90 was significantly associated with lower score in all domains of 
physical components, compared to the reference, with most evident difference in physical 
functioning (-3.42 [95%CI: -5.50 to -1.35]) followed by role physical, general health and 
bodily pain (Table 2). ABI 0.90-0.99 showed lower score in all physical domains 
compared to the reference as well, but the difference reached significance only for “role 
physical” domain (-1.87 [95%CI: -3.58 to -0.16]) and bodily pain domain (-1.59 [95%CI: 
-3.13 to -0.05]). As anticipated, more evident dose-response association between lower 
ABI and reduced physical QOL domains were observed for Models 1 and 2 
(Supplementary Table 2 and 3).  
 For mental components, the association was overall weaker than physical 
components but ABI categories <1.00 had significantly lower vitality score compared to 
the reference group (ABI 1.10-1.19) (-1.54 [95%CI: -2.25 to -0.83] for ABI <0.9 and -1.38 
[95%CI -1.98 to -0.78] for ABI 0.90-0.99). Similar results were observed in Model 1 and 2 
except for the presence of significant association between low ABI and role emotional 
domain as well as more evident ABI-vitality association. High ABI did not demonstrate 
significantly lower score in any of physical and mental domains. 
 
The Other QOL parameters 
We observed dose-response relationships between ABI and the other physical QOL 
parameters (Table 3). Consistent with the results for physical components in SF-12, low 
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ABI (<0.90) was significantly associated with all three physical activity parameters (OR: 
1.34 [95%CI: 1.09 to 1.64] for “low” leisure time exercise, 1.35 [95%CI: 1.21 to 1.50] for 
“low” leisure time activity and 1.43 [95%CI: 1.25 to 1.63] for “low” leisure time walk) 
compared to the reference ABI. The significant impairments on leisure time activity level 
and walking frequency were also observed in borderline low ABI 0.90-0.99. Of note, low 
normal ABI 1.00-1.09 was also significantly associated with the three physical activity 
parameters (OR: 1.21 [95%CI: 1.09 to 1.35] for “low” leisure time exercise, 1.15 [95%CI: 
1.04 to 1.26] for “low” leisure time activity and 1.24 [95%CI: 1.11 to 1.39] for “low” leisure 
time walk). More evident associations were observed in Models 1 and 2. (Supplementary 
Table 4 and 5) 
 The other mental parameters demonstrate weaker associations with lower ABI 
compared to the other physical parameters (Table 3). Although a general dose-response 
relationship was observed for depression, none of the odds ratios were significant for low 
ABI categories. The odds of hopeless feeling were only significantly higher in borderline 
low ABI 0.90-0.99 compared to the reference ABI. 
 
Subgroup analysis 
Overall, dose-response associations with lower ABI (<1.00) were observed for poor 
physical QOL components based on SF-12 in most subgroups tested (Supplementary 
Table 6), but not for mental QOL components (Supplementary Table 7). Notably, for the 
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other physical QOL parameters, the association between lower ABI and lower leisure 
time exercise, activity, and walking was consistently more evident in participants without 
history of CVD than in those with history of CVD with significant interaction for “low” 
leisure time activity (p for interaction = 0.007) and “low” leisure time walk (p for interaction 
< 0.001) (Supplementary Table 8). Similar pattern was observed for reduced kidney 
function status. In addition relatively stronger association between lower ABI and 
impaired physical actives parameters was found in Caucasian compared to African 
American, but the effect modification was not significant.  
For mental components, reflecting overall weak association with ABI, the 
association was not evident in any subgroups except within some racial groups for 
depression and hopeless feeling. Specifically, lower ABI (<1.00) was associated with 
higher odds of depression and hopeless feeling compared to ABI ≥1.00 in Caucasian, 
whereas lower ABI was related to lower odds of those mental conditions in African 
American. (Supplementary Table 9)
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DISCUSSION 
This study quantified the association between ABI values and several domains of QOL 
among community-dwelling older adults in the US. With ABI 1.10-1.19 as reference group, 
low ABI <0.90 and borderline low ABI (0.90-0.99) were associated with poorer status of 
QOL parameters, with general dose-response relationship. The contribution of lower ABI 
was more evident for physical components of QOL than for mental components in SF-12. 
The association of ABI with physical QOL was confirmed in other parameters such as 
leisure time exercise, activity, and walking as well. Of note, lower ABI was significantly 
associated with a mental domain, vitality. Notably, poor QOL status for physical 
components was observed even among those without other CVD (i.e., coronary disease, 
stroke, and heart failure) or clinical conditions tightly related to PAD (e.g., diabetes and 
reduced kidney function). 
 The more evident association of low ABI with physical components of QOL status 
than mental components is consistent with previous studies investigating clinical 
populations.33-35 Of note, our study is first to confirm this aspect in community-dwelling 
older adults not selected for clinical conditions and hence not susceptible to spectrum 
bias. There are several potential mechanisms linking PAD to the impairments for physical 
components of QOL. Individuals with low ABI often have other CVDs and comorbidities, 
which may reduce QOL. However, the association of ABI with physical domains of QOL 
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was independent of those comorbidities. In terms of PAD-specific potential mechanisms, 
decreased blood flow to leg can induce skeletal muscle atrophy and denervation through 
repeated ischemia.36 Leg pain or discomfort can additionally contribute to limited physical 
ability. In addition, fear of falling was reported among those with intermittent claudication37 
and could further impact physical activity. 
 Although weaker than physical domains, low ABI was significantly associated with 
a mental element of QOL, i.e., vitality, in our study, which is in line with previous studies 
showing stronger association of low ABI with vitality than other mental domains. We 
observed a higher odds of hopeless feeling in ABI 0.90-0.99 compared to ABI 1.10-1.19, 
but we should interpret this result with caution since we did not necessarily observe 
higher odds in ABI <0.9. Although the exact mechanisms for PAD to impact vitality are not 
clear, limited physical activity as well as working ability due to PAD may play a role. Also, 
aforementioned leg pain or fear of falling due to PAD may contribute to reduced mental 
elements of QOL.  
 Although a weaker association was seen among individuals with history of CVD 
than those without, the contribution of low ABI to physical QOL parameters was 
qualitatively consistent across all subgroups tested in our study. The weaker association 
among those with history of CVD may be due to the fact that many participants with prior 
CVD had reduced QOL and ABI may not considerably contribute to further discrimination 
beyond other CVDs. Similar Effect modification was observed for reduced kidney function 
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status. On the other hand, we observed a significant qualitative racial interaction for low 
ABI and depression/hopeless feeling, with positive associations in Caucasian but 
negative relations in African American. The potential background for this significant 
interaction was not clear, but we should keep in mind that we tested five subgroups 
without a priori hypothesis for the direction of interaction and there were relatively small 
number of African American in our study. Thus, our results should be considered 
hypothesis generating and confirmation in other settings is needed. 
 Our findings of the association of low ABI and impaired QOL among 
community-dwelling older adults may have some clinical and public health implications. 
Maintaining physical activity is an important element for older adults’ ability to sustain 
independent living. Since several lifestyle (e.g., smoking cessation or 
supervised-exercise) or medical (e.g., Cilostazol or revascularization) interventions have 
demonstrated to improve physical function in PAD patients, it seems important to identify 
the contribution of PAD, if any, to the reduction of physical-related QOL in older adults. It 
is important to keep in mind that reduced QOL was also observed in those with borderline 
low ABI in our study. Further studies would be needed to assess whether the 
aforementioned PAD-specific interventions would comprehensively improve 
physical-related QOL as well as vitality in those with low ABI.  
 There are several limitations in our study. First, given a cross-sectional analysis, 
we cannot infer temporality for low ABI and poor QOL status. Second, it is possible that 
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those with very low ABI and/or severely reduced QOL could not attend ARIC visit 5, 
raising possibility that our results may underestimate the ABI-QOL relationship. Third, the 
ARIC Study did not collect information on leg pain at visit 5. Fourth, generalization of our 
findings to racial/ethnic groups other than Caucasian and African American needs to be 
done carefully. Finally, as true in any observational studies, we cannot deny the possibility 
of residual confounding. 
 In conclusion, among older adults in the community, low ABI and borderline low 
ABI were associated with poor QOL status. The association was particularly evident for 
physical components of QOL, but a mental domain, vitality, was associated with low ABI 
as well. Further studies are warranted to evaluate the causality of ABI in the reduction of 
QOL and, if so, to explore whether the management of PAD improves QOL among 






Table 1. Participant’s characteristics description across ABI categories 
Characteristics 
















Age, mean (SD) 75.4 (5.0) 77.3 (5.5) 76.0 (5.6) 75.3 (5.1) 75.0 (4.8) 74.8 (4.9) 75.5 (4.8) <0.001 
Sex (Females) 2948 (57.6%) 214 (53.2%) 298 (70.0%) 878 (71.2%) 1138 (59.9%) 289 (41.6%) 131 (28.5%) <0.001 
Ethnicity (African American) 1113 (21.8%) 164 (40.8%) 133 (31.2%) 352 (28.5%) 352 (18.5%) 66 (9.5%) 46 (10.0%) <0.001 
Lower Education Level 2819 (55.1%) 258 (64.2%) 264 (62.0%) 732 (59.3%) 1029 (54.2%) 339 (48.8%) 197 (42.9%) <0.001 
Lower self-indicated economic status 2367 (46.3%) 232 (57.7%) 229 (53.8%) 642 (52.0%) 828 (43.6%) 267 (38.5%) 169 (36.8%) <0.001 
Current Smoker 2805 (58.0%) 274 (73.7%) 249 (62.4%) 662 (56.8%) 1003 (55.8%) 352 (53.3%) 265 (60.0%) <0.001 
Current Drinker 4059 (79.4%) 314 (78.1%) 328 (77.0%) 933 (75.6%) 1537 (80.9%) 571 (82.3%) 376 (81.9%) <0.001 
Body Mass Index, mean (SD) 28.6 (5.5) 28.9 (5.9) 29.5 (6.6) 29.0 (5.7) 28.2 (5.1) 28.0 (4.7) 29.1 (5.6) <0.001 
Total Cholesterol, mean (SD) 4.7 (1.1) 4.6 (1.1) 4.8 (1.1) 4.8 (1.1) 4.7 (1.1) 4.6 (1.0) 4.4 (1.0) <0.001 
Diabetes 1606 (31.4%) 173 (43.0%) 142 (33.3%) 388 (31.4%) 546 (28.7%) 205 (29.5%) 152 (33.1%) <0.001 
Hypertension 3774 (73.8%) 347 (86.3%) 338 (79.3%) 953 (77.2%) 1343 (70.7%) 481 (69.3%) 312 (68.0%) <0.001 
CHD History 734 (14.3%) 115 (28.6%) 72 (16.9%) 153 (12.4%) 229 (12.1%) 88 (12.7%) 77 (16.8%) <0.001 
Heart Failure History 239 (4.7%) 58 (14.4%) 28 (6.6%) 56 (4.5%) 59 (3.1%) 16 (2.3%) 22 (4.8%) <0.001 
Stroke History 174 (3.4%) 29 (7.2%) 26 (6.1%) 36 (2.9%) 50 (2.6%) 18 (2.6%) 15 (3.3%) <0.001 
Lung Disease 566 (11.1%) 72 (17.9%) 64 (15.0%) 155 (12.6%) 185 (9.7%) 54 (7.8%) 36 (7.8%) <0.001 
Reduced Kidney Function  1424 (27.8%) 176 (43.8%) 160 (37.6%) 351 (28.4%) 463 (24.4%) 156 (22.5%) 118 (25.7%) <0.001 
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Table 2. The difference in QOL scores across ABI categories. 
QOL Domains 
ABI categories† (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
Coefficient∆ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Physical Components -3.26 (-5.60 to -0.92) -2.23 (-4.07 to -0.39) -0.62 (-1.42 to 0.19) 0 -0.56 (-1.71 to 0.59) -0.13 (-1.09 to 0.82) 
Physical Functioning -3.42 (-5.50 to -1.35) -1.71 (-3.94 to 0.52) -0.68 (-1.58 to 0.22) 0 -0.21 (-1.61 to 1.18) -0.43 (-1.58 to 0.71) 
Role Physical -2.76 (-4.98 to -0.55) -1.87 (-3.58 to -0.16) -0.90 (-2.25 to 0.45) 0 -0.45 (-1.48 to 0.58) -0.01 (-1.64 to 1.62) 
Bodily Pain -1.99 (-3.77 to -0.22) -1.59 (-3.13 to -0.05) -0.15 (-0.81 to 0.52) 0 -1.01 (-2.48 to 0.45) -0.03 (-1.42 to 1.35) 
General Health -2.31 (-3.52 to -1.09) -1.55 (-3.30 to 0.20) -0.16 (-1.36 to 1.04) 0 0.00 (-1.16 to 1.16) 0.50 (-0.63 to 1.63) 
Mental Components -0.07 (-2.21 to 2.06) 0.15 (-0.96 to 1.26) 0.06 (-0.54 to 0.66) 0 0.09 (-0.62 to 0.79) 0.37 (-0.44 to 1.19) 
Mental Health -0.62 (-2.47 to 1.23) 0.01 (-0.51 to 0.53) 0.29 (-0.59 to 1.17) 0 0.04 (-1.15 to 1.23) 0.47 (-0.64 to 1.57) 
Role Emotional -1.41 (-2.98 to 0.16) -0.42 (-1.49 to 0.64) -0.74 (-1.49 to 0.00) 0 -0.13 (-0.91 to 0.65) -0.17 (-0.97 to 0.64) 
Social Functioning -0.58 (-2.07 to 0.92) -0.54 (-1.99 to 0.92) 0.02 (-0.42 to 0.46) 0 -0.02 (-1.23 to 1.19) 0.09 (-1.27 to 1.45) 
Vitality -1.54 (-2.25 to -0.83) -1.38 (-1.98 to -0.78) -0.18 (-0.49 to 0.13) 0 -0.31 (-0.88 to 0.26) 0.42 (-0.03 to 0.88) 
∆ Linear regression coefficient: It represents the difference in QOL score between a given ABI category to the reference category (1.10-1.19), adjusted for all 




Table 3. Odds-ratio of other QOL parameters across ABI categories. 
Other QOL 
Parameters 
ABI categories† (n) 
<0.90  0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
# low QOL/total  
OR∆ (95% CI) 
# low QOL/total 
OR (95% CI) 
# low QOL/total 
OR (95% CI) 
Ref 
# low QOL/total 
OR (95% CI) 
# low QOL/total 
OR (95% CI) 
Physical Activity        
“Low” leisure time exercise 
230/402 
1.34 (1.09 to 1.64) 
248/426 
1.38 (0.98 to 1.93) 
656/1,234 




1.01 (0.79 to 1.30) 
191/459  
0.95 (0.68 to 1.32) 
“Low” leisure time activity 
101/402 
1.35 (1.21 to 1.50) 
103/426 
1.26 (1.13 to 1.40) 
253/1,234 




0.74 (0.62 to 0.88) 
59/459 
0.76 (0.60 to 0.98) 
“Low” leisure time walk 
158/402 
1.43 (1.25 to 1.63) 
162/426 
1.38 (1.08 to 1.76) 
413/1,234 




0.94 (0.77 to 1.14) 
110/459 
0.93 (0.80 to 1.08) 
Mental Health 
      
 Depression 
46/402 
1.51 (0.87 to 2.62) 
35/426 
1.19 (0.79 to 1.81) 
91/1,234 




0.79 (0.46 to 1.34) 
19/459 
0.91 (0.62 to 1.32) 
 Hopeless Feeling 
55/402 
1.13 (0.97 to 1.31) 
56/426 
1.20 (1.07 to 1.33) 
159/1,234 




0.91 (0.63 to 1.32) 
35/459 
0.94 (0.53 to 1.66) 













Supplementary Table 1. Description of participant’s SF-12 QOL parameters across ABI categories. 
†: mean (SD) was reported.
Characteristics 
ABI categories† (n) 
All (5,115) <0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) P-value 
Physical Component† 46.8 (9.9) 41.9 (10.5) 43.6 (10.8) 46.3 (10.0) 48.1 (9.2) 48.2 (9.5) 48.1 (9.0) <0.001 
Physical Functioning† 47.9 (10.4) 43.0 (11.5) 45.1 (11.6) 47.2 (10.6) 49.0 (9.7) 49.7 (9.7) 49.0 (9.5) <0.001 
Role Physical† 48.5 (9.1) 44.5 (9.7) 46.1 (9.6) 47.9 (9.3) 49.6 (8.8) 49.6 (8.5) 49.5 (8.5) <0.001 
Bodily Pain† 48.7 (10.1) 46.1 (10.9) 46.5 (11.6) 48.5 (10.1) 49.5 (9.7) 49.0 (9.7) 49.8 (9.3) <0.001 
General Health† 50.1 (9.7) 44.8 (10.8) 47.1 (10.2) 49.5 (9.4) 51.2 (9.3) 52.1 (8.9) 52.2 (8.8) <0.001 
Mental Component † 55.5 (7.5) 54.6 (9.0) 55.1 (8.4) 55.2 (7.9) 55.5 (7.0) 56.0 (6.8) 56.4 (6.4) 0.002 
Mental Health†  54.9 (7.9) 53.3 (9.1) 54.0 (8.8) 54.7 (8.0) 55.1 (7.6) 55.7 (7.1) 56.2 (7.0) <0.001 
Role Emotional† 51.9 (7.5) 49.7 (9.4) 51.1 (7.9) 51.1 (8.2) 52.5 (6.9) 52.7 (6.4) 52.6 (6.8) <0.001 
Social Functioning† 52.7 (7.9) 51.0 (9.5) 51.6 (8.7) 52.5 (8.0) 53.1 (7.8) 53.4 (7.0) 53.4 (6.9) <0.001 
Vitality† 53.1 (9.1) 50.4 (9.6) 50.9 (9.3) 52.8 (9.1) 53.8 (8.9) 53.9 (8.7) 54.3 (8.6) <0.001 
 22 
Supplementary Table 2. The difference in QOL scores across ABI categories using Model 1†.   
QOL Domains 
ABI categories† (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
Coefficient∆ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI)  Coefficient (95% CI) 
Physical Components -5.28 (-8.32 to -2.24) -3.72 (-5.03 to -2.41) -1.29 (-1.82 to -0.75) 0 -0.39 (-1.98 to 1.20) -0.72 (-1.90 to 0.47) 
Physical Functioning -5.41 (-8.11 to -2.71) -3.17 (-5.02 to -1.33) -1.33 (-2.12 to -0.55) 0 -0.03 (-2.05 to 2.00) -1.01 (-2.78 to 0.76) 
Role Physical -4.33 (-7.14 to -1.52) -3.03 (-4.01 to -2.04) -1.41 (-2.34 to -0.48) 0 -0.32 (-1.21 to 0.58) -0.44 (-2.02 to 1.14) 
Bodily Pain -3.21 (-5.24 to -1.19) -2.60 (-4.34 to -0.85) -0.61 (-0.94 to -0.29) 0 -0.91 (-2.59 to 0.77) -0.47 (-2.29 to 1.34) 
General Health -4.12 (-5.97 to -2.26) -2.71 (-4.26 to -1.17) -0.69 (-2.05 to 0.68) 0 0.14 (-1.26 to 1.54) 0.16 (-0.35 to 0.68) 
Mental Components -0.34 (-2.25 to 1.57) -0.01 (-1.04 to 1.03) 0.00 (-0.60 to 0.61) 0 0.11 (-0.54 to 0.76) 0.37 (-0.51 to 1.26) 
Mental Health -1.24 (-2.84 to 0.36) -0.42 (-0.77 to -0.06) 0.11 (-0.73 to 0.96) 0 0.11 (-1.00 to 1.21) 0.39 (-0.82 to 1.60) 
Role Emotional -2.00 (-3.60 to -0.39) -0.83 (-2.10 to 0.43) -0.93 (-1.70 to -0.16) 0 -0.09 (-0.93 to 0.75) -0.32 (-1.44 to 0.79) 
Social Functioning -1.28 (-2.88 to 0.32) -1.01 (-2.61 to 0.59) -0.19 (-0.51 to 0.13) 0 0.05 (-1.23 to 1.34) -0.07 (-1.52 to 1.39) 
Vitality -2.89 (-4.54 to -1.25) -2.41 (-3.11 to -1.71) -0.62 (-1.25 to 0.02) 0 -0.20 (-0.90 to 0.50) 0.05 (-0.83 to 0.94) 
∆ Linear regression coefficient: It represents the difference in QOL score between a given ABI category to the reference category (1.10-1.19). Negative 
coefficient means lower QOL score in the given category comparing to the reference group. Red & bold indicates statistically significant results. 
†Model 1 covariates: age, sex, ethnicity, education level, self-indicated economics status.
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Supplementary Table 3. The difference in QOL scores across ABI categories using Model 2†.   
QOL Domains 
ABI categories† (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
Coefficient∆ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI)  Coefficient (95% CI) 
Physical Components -4.40 (-6.88 to -1.92) -2.82 (-4.28 to -1.36) -0.84 (-1.46 to -0.23) 0 -0.38 (-1.62 to 0.86) -0.07 (-0.80 to 0.66) 
Physical Functioning -4.62 (-6.83 to -2.42) -2.32 (-4.19 to -0.46) -0.92 (-1.71 to -0.14) 0 -0.03 (-1.59 to 1.54) -0.37 (-1.71 to 0.96) 
Role Physical -3.65 (-6.01 to -1.28) -2.34 (-3.76 to -0.91) -1.08 (-2.30 to 0.14) 0 -0.31 (-1.28 to 0.65) 0.03 (-1.36 to 1.42) 
Bodily Pain -2.59 (-4.23 to -0.94) -1.91 (-3.69 to -0.14) -0.27 (-0.92 to 0.37) 0 -0.91 (-2.36 to 0.54) 0.01 (-1.40 to 1.42) 
General Health -3.27 (-4.76 to -1.79) -2.06 (-3.54 to -0.57) -0.35 (-1.59 to 0.89) 0 0.16 (-1.07 to 1.39) 0.56 (-0.25 to 1.38) 
Mental Components -0.17 (-2.32 to 1.98) 0.09 (-1.07 to 1.24) 0.03 (-0.57 to 0.63) 0 0.11 (-0.62 to 0.84) 0.38 (-0.46 to 1.23) 
Mental Health -0.92 (-2.75 to 0.91) -0.15 (-0.72 to 0.42) 0.22 (-0.62 to 1.06) 0 0.09 (-1.06 to 1.25) 0.49 (-0.63 to 1.60) 
Role Emotional -1.73 (-3.33 to -0.14) -0.61 (-1.84 to 0.63) -0.82 (-1.59 to -0.05) 0 -0.08 (-0.85 to 0.69) -0.15 (-1.04 to 0.75) 
Social Functioning -1.03 (-2.55 to 0.49) -0.76 (-2.40 to 0.88) -0.08 (-0.48 to 0.33) 0 0.06 (-1.20 to 1.31) 0.12 (-1.27 to 1.50) 
Vitality -2.17 (-3.41 to -0.93) -1.75 (-2.25 to -1.25) -0.32 (-0.73 to 0.10) 0 -0.21 (-0.77 to 0.36) 0.46 (-0.12 to 1.05) 
∆ Linear regression coefficient: It represents the difference in QOL score between a given ABI category to the reference category (1.10-1.19). Negative 
coefficient means lower QOL score in the given category comparing to the reference group. Red & bold indicates statistically significant results. 
†Model 2 covariates: age, sex, ethnicity, education level, self-indicated economics status, body mass index, current smoking status, current drinking status, total 




Supplementary Table 4. Odds-ratio of other QOL parameters across ABI categories using Model 1†. 
Other QOL 
Parameters 
ABI categories† (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
OR∆ (95% CI) OR (95% CI) OR (95% CI) Ref OR (95% CI) OR (95% CI) 
Physical Activity        
“Low” leisure time exercise 1.51 (1.20 to 1.90) 1.54 (1.06 to 2.23) 1.28 (1.13 to 1.45) 1 1.01 (0.80 to 1.28) 1.01 (0.71 to 1.42) 
“Low” leisure time activity 1.74 (1.51 to 2.01) 1.58 (1.36 to 1.83) 1.26 (1.11 to 1.42) 1 0.74 (0.59 to 0.92) 0.90 (0.67 to 1.20) 
“Low” leisure time walk 1.62 (1.42 to 1.85) 1.56 (1.17 to 2.09) 1.31 (1.16 to 1.49) 1 0.93 (0.76 to 1.13) 0.99 (0.84 to 1.16) 
Mental Health       
Depression 1.97 (1.14 to 3.41) 1.46 (1.00 to 2.14) 1.32 (1.10 to 1.59) 1 0.78 (0.48 to 1.27) 1.02 (0.65 to 1.61) 
Hopeless Feeling 1.33 (1.10 to 1.61) 1.37 (1.26 to 1.50) 1.39 (1.03 to 1.88) 1 0.91 (0.64 to 1.30) 1.02 (0.56 to 1.84) 
∆ Logistic regressions were applied to assess the 5 binary other QOL parameters. Red & bold indicates statistically significant results. 
†Model 1 covariates: age, sex, ethnicity, education level, self-indicated economics status. 
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Supplementary Table 5. Odds-ratio of other QOL parameters across ABI categories using Model 2†. 
Other QOL 
Parameters 
ABI categories† (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
OR∆ (95% CI) OR (95% CI) OR (95% CI) Ref OR (95% CI) OR (95% CI) 
Physical Activity        
“Low” leisure time exercise 1.38 (1.12 to 1.71) 1.41 (1.00 to 1.99) 1.22 (1.10 to 1.36) 1 1.01 (0.79 to 1.29) 0.95 (0.68 to 1.33) 
“Low” leisure time activity 1.51 (1.38 to 1.66) 1.36 (1.18 to 1.57) 1.17 (1.09 to 1.27) 1 0.73 (0.60 to 0.90) 0.78 (0.58 to 1.04) 
“Low” leisure time walk 1.50 (1.33 to 1.69) 1.44 (1.14 to 1.82) 1.26 (1.13 to 1.42) 1 0.93 (0.77 to 1.12) 0.92 (0.79 to 1.07) 
Mental Health       
Depression 1.76 (0.99 to 3.13) 1.32 (0.85 to 2.03) 1.27 (1.04 to 1.56) 1 0.78 (0.47 to 1.28) 0.92 (0.60 to 1.42) 
Hopeless Feeling 1.21 (1.01 to 1.45) 1.27 (1.12 to 1.44) 1.35 (0.99 to 1.83) 1 0.91 (0.63 to 1.30) 0.95 (0.53 to 1.71) 
∆ Logistic regressions were applied to assess the 5 binary other QOL parameters. Red & bold indicates statistically significant results. 
†Model 2 covariates: age, sex, ethnicity, education level, self-indicated economics status, body mass index, current smoking status, current drinking status, total 













Supplementary Table 6. The difference in Physical Component Summary scores across ABI categories in different subgroups. 
Subgroups 
ABI categories† (n) 
<0.90 0.90-0.99 1.00-1.09 1.10-1.19 1.20-1.29 ≥1.30 
Coefficient∆ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Sex*       
Males -3.84 (-8.25 to 0.57) -1.72 (-3.68 to 0.24) -0.46 (-1.90 to 0.98) 0 0.57 (-0.30 to 1.45) 0.28 (-1.01 to 1.56) 
Females -2.56 (-5.39 to 0.27) -2.44 (-4.41 to -0.48) -0.74 (-2.20 to 0.73) 0 -1.88 (-4.33 to 0.58) -0.45 (-2.73 to 1.83) 
P value for interaction 0.014      
Ethnicity 
      
Caucasian -3.68 (-7.13 to -0.23) -2.00 (-4.53 to 0.53) -0.48 (-1.40 to 0.45) 0 -0.37 (-0.87 to 0.12) 0.05 (-0.90 to 1.00) 
African American -3.05 (-3.78 to -2.31) -2.73 (-3.79 to -1.68) -0.88 (-1.49 to -0.27) 0 -2.47 (-6.31 to 1.36) -1.54 (-3.01 to -0.07) 
P value for interaction 0.051      
CVD History*       
No CVD history -4.54 (-7.70 to -1.38) -2.56 (-5.23 to 0.10) -0.67 (-1.73 to 0.39) 0 -0.96 (-2.29 to 0.38) -0.42 (-2.20 to 1.36) 
CVD history -1.10 (-2.82 to 0.62) -1.01 (-3.62 to 1.60) -0.22 (-1.15 to 0.71) 0 1.58 (-0.64 to 3.80) 1.20 (-2.02 to 4.41) 
P value for interaction 0.001      
Diabetes       
No Diabetes  -3.60 (-7.10 to -0.09) -2.56 (-4.81 to -0.31) -0.95 (-2.64 to 0.74) 0 -1.05 (-2.43 to 0.33) -0.39 (-1.76 to 0.98) 
Diabetes  -2.37 (-3.20 to -1.53) -1.32 (-5.83 to 3.18) 0.19 (-1.25 to 1.64) 0 0.63 (-0.88 to 2.14) 0.71 (-1.52 to 2.94) 
P value for interaction 0.388      
Reduced Kidney Function  
      
Not Reduced  -3.33 (-5.59 to -1.06) -2.78 (-4.79 to -0.77) -1.26 (-2.46 to -0.07) 0 -1.00 (-2.16 to 0.17) -0.04 (-1.64 to 1.56) 
Reduced   -2.86 (-5.40 to -0.31) -0.87 (-2.94 to 1.20) 1.14 (-0.14 to 2.43) 0 0.84 (-2.85 to 4.52) -0.26 (-1.66 to 1.13) 
P value for interaction 0.096      
∆ Linear regression coefficient: It represents the difference in Mental Component Summary score between ABI category <1.00 and the reference category 
(≥1.00), adjusted for all covariates. Negative coefficient means lower Mental Component Summary score in the ABI category <1.00 comparing to the reference 
group. Red & bold indicates statistically significant results. Global F test were used to test significant interaction terms. 
 27 
Supplementary Table 7. The difference in Mental Component Summary scores across ABI categories in different subgroups 
Subgroups 
ABI categories† (n) 
<0.90 0.90-0.99 1.00-1.09 1.10-1.19 1.20-1.29 ≥1.30 
Coefficient∆ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Sex       
Males 0.27 (-2.23 to 2.78) -0.71 (-2.16 to 0.75) 0.62 (-0.20 to 1.44) 0 0.19 (-1.01 to 1.40) 0.19 (-0.74 to 1.12) 
Females -0.36 (-2.21 to 1.48) 0.47 (-1.46 to 2.40) -0.20 (-0.88 to 0.49) 0 0.06 (-1.90 to 2.02) 0.95 (-0.74 to 2.64) 
P value for interaction 0.28      
Ethnicity 
      
Caucasian -0.39 (-2.85 to 2.07) 0.09 (-1.37 to 1.55) 0.20 (-0.41 to 0.81) 0 0.26 (-0.27 to 0.80) 0.58 (-0.15 to 1.31) 
African American 0.24 (-1.55 to 2.04) 0.14 (-0.55 to 0.83) -0.41 (-2.08 to 1.25) 0 -0.73 (-1.89 to 0.43) -0.50 (-1.00 to -0.01) 
P value for interaction 0.152      
CVD History       
No CVD history -0.39 (-2.87 to 2.10) 0.39 (-0.84 to 1.61) 0.04 (-0.63 to 0.71) 0 0.24 (-0.42 to 0.91) 0.35 (-0.58 to 1.28) 
CVD history 0.29 (-1.57 to 2.16) -0.53 (-1.68 to 0.63) 0.20 (-1.39 to 1.79) 0 -0.81 (-2.39 to 0.77) 0.31 (-0.14 to 0.76) 
P value for interaction 0.011      
Diabetes       
No Diabetes  -0.37 (-1.73 to 1.00) 0.09 (-1.25 to 1.44) -0.05 (-1.21 to 1.11) 0 0.30 (-0.08 to 0.67) 0.47 (-1.14 to 2.09) 
Diabetes  0.36 (-2.86 to 3.57) 0.61 (-2.23 to 3.45) 0.33 (-1.87 to 2.53) 0 -0.27 (-2.17 to 1.63) 0.31 (-1.13 to 1.76) 
P value for interaction 0.976      
Reduced Kidney Function  
      
Not Reduced  0.31 (-2.78 to 3.41) 0.59 (0.09 to 1.08) 0.44 (-0.22 to 1.10) 0 0.22 (-0.19 to 0.64) 0.37 (-1.09 to 1.83) 
Reduced   -0.96 (-3.85 to 1.93) -0.85 (-2.84 to 1.14) -0.99 (-2.60 to 0.61) 0 -0.35 (-3.59 to 2.89) 0.19 (-0.84 to 1.21) 
P value for interaction 0.031      
∆ Linear regression coefficient: It represents the difference in Mental Component Summary score between ABI category <1.00 and the reference category 
(≥1.00), adjusted for all covariates. Negative coefficient means lower Mental Component Summary score in the ABI category <1.00 comparing to the reference 
group. Red & bold indicates statistically significant results. Global F test were used to test significant interaction terms. 
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Supplementary Table 8. Odds-ratio of other physical activity parameters for lower ABI (<1.00) in different subgroups. 
Subgroups 
Physical Activity Parameters 
“Low” leisure time exercise “Low” leisure time activity “Low” leisure time walk 
Case/N† OR∆ (95% CI) Case/N OR∆ (95% CI) Case/N OR (95% CI) 
Sex  
 
   
 Males 162/316  1.30 (0.91 to 1.87) 56/316  1.10 (0.81 to 1.48) 104/316  1.34 (1.05 to 1.71) 
Females 316/512  1.25 (1.04 to 1.50) 148/512  1.41 (1.18 to 1.69) 216/512  1.30 (1.18 to 1.43) 
P value for interaction 0.854 0.661 0.629 
Ethnicity  
 
   
 
Caucasian 314/531  1.38 (1.01 to 1.88) 122/531  1.29 (1.14 to 1.47) 206/531  1.38 (1.14 to 1.66) 
African American 164/297  1.10 (0.98 to 1.23) 82/297  1.27 (1.24 to 1.30) 114/297  1.18 (1.07 to 1.30) 
P value for interaction 0.150 0.686 0.278 
CVD History       
No CVD history 329/565  1.31 (1.01 to 1.70) 149/565  1.50 (1.34 to 1.69) 226/565  1.41 (1.24 to 1.61) 
CVD history 149/263  1.17 (0.91 to 1.51) 55/263  0.96 (0.69 to 1.32) 94/263  1.08 (0.84 to 1.39) 
P value for interaction 0.185 0.007 < 0.001 
Diabetes       
No Diabetes  276/513  1.14 (0.83 to 1.56) 111/513  1.47 (1.04 to 2.07) 192/513  1.40 (1.04 to 1.88) 
Diabetes  202/315  1.57 (1.21 to 2.03) 93/315  1.08 (0.79 to 1.48) 128/315  1.18 (0.88 to 1.57) 
P value for interaction 0.315 0.262 0.352 
Reduced Kidney Function   
 
   
 
Not Reduced  283/492  1.35 (1.06 to 1.71) 117/492  1.42 (1.24 to 1.62) 176/492  1.35 (1.17 to 1.56) 
Reduced   195/336  1.15 (0.86 to 1.53) 87/336  1.15 (0.88 to 1.50) 144/336  1.26 (1.04 to 1.53) 
P value for interaction 0.383 0.069 0.662 
† Number of individuals having outcome with ABI < 1.00 for each subgroup/ Total number of individuals with ABI < 1.00 for each subgroup 
∆ Logistic regressions were applied to assess the ratio of odds for 3 binary physical activity parameters between ABI category <1.00 and the reference  
category (≥1.00). Red & bold indicates statistically significant results. 
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Supplementary Table 9. Odds-ratio of other mental health parameters for lower ABI (<1.00) in different subgroups. 
Subgroups 
 Mental Health Parameters 
  Depression Hopeless feeling 




 Males 24/316  1.22 (0.62 to 2.39) 37/316  1.09 (0.84 to 1.42) 
Females 57/512  1.29 (0.68 to 2.43) 74/512  1.04 (0.78 to 1.40) 





Caucasian 51/531  1.65 (1.05 to 2.59) 70/531  1.23 (1.10 to 1.36) 
African American 30/297  0.84 (0.74 to 0.96) 41/297  0.83 (0.78 to 0.88) 
P value for interaction 0.001 < 0.001 
CVD History     
No CVD history 52/565  1.20 (0.69 to 2.09) 77/565  1.06 (0.70 to 1.59) 
CVD history 29/263  1.50 (0.88 to 2.58) 34/263  1.11 (0.79 to 1.57) 
P value for interaction 0.036 0.936 
Diabetes     
No Diabetes  40/513  1.23 (0.51 to 2.94) 64/513  1.15 (0.89 to 1.50) 
Diabetes  41/315  1.28 (0.81 to 2.02) 47/315  0.91 (0.61 to 1.37) 
P value for interaction 0.975 0.070 




Not Reduced  41/492  1.11 (0.70 to 1.75) 61/492  1.05 (0.73 to 1.51) 
Reduced   40/336  1.63 (0.73 to 3.62) 50/336  1.07 (0.81 to 1.40) 
P value for interaction 0.271 0.809 
† Number of individuals having outcome with ABI < 1.00 for each subgroup / Total number of individuals with ABI < 1.00 for each subgroup 
∆ Logistic regressions were applied to assess the ratio of odds for 2 binary mental health parameters between ABI category <1.00 and the  
reference category (≥1.00). Red & bold indicates statistically significant results.
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